Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: A five-year randomized prospective study
Author:
Publisher
Wiley
Subject
Transplantation,Hepatology,Surgery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.21905/fullpdf
Reference35 articles.
1. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation;US Multicenter FK506 Liver Study Group;N Engl J Med,1994
2. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation. A report of the United States FK506 Study Group;Wiesner;Transplantation,1998
3. Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection;European FK506 Multicentre Liver Study Group;Lancet,1994
4. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection;European Mycophenolate Mofetil Cooperative Study Group;Lancet,1995
5. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation;Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group;Transplantation,1996
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Liver transplantation: the recipient;Living Donor Organ Transplantation;2024
2. Infections in liver transplantation;Viral, Parasitic, Bacterial, and Fungal Infections;2023
3. New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy;Cureus;2022-03-29
4. Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective;Journal of Hepatology;2021-11
5. Outcomes of Kidney Allograft and Recipient Survival After Liver Transplantation by Induction Type in the United States;Liver Transplantation;2021-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3